Fenofibrate

Producers shown on SFDA

(Record date:02/09/2021）

Producers shown on EP

(Quoted from EP website；record date:02/09/2021）

Producer:Chongqing Southwest No.2 Pharmaceutical Factory Co., Ltd., formerly known as Chongqing Southwest Pharmaceutical second factory, is a modern comprehensive pharmaceutical enterprise integrating the production of chemical APIs, pharmaceutical and chemical intermediates and solid preparations. Founded in 1958, it has more than 50 years of experience in the development and production of APIs, preparations and pharmaceutical and chemical intermediates. In 2005, the enterprise successfully completed the construction of the "Three Gorges Reservoir area environmental treatment and relocation combined with enterprise technological progress project" approved by the national development and Reform Commission, and the production base was relocated to Jiangjin Degan Industrial Park in Chongqing. The new production base covers an area of 130000 square meters and has more than 300 employees.

The company has a GMP compliant API production workshop and solid preparation production workshop, mainly producing API and OEM pharmaceutical and chemical intermediates. The enterprise has the autonomy of foreign trade import and export, and has established trade exchanges with many countries and regions in the world.

Staff size:200-299 persons

Registered capital:RMB 100 million

Producer:Kaifeng Pharmaceutical (Group) Co., Ltd. (hereinafter referred to as "Kaifeng Pharmaceutical Group") was founded in May 1949. Its predecessor is Kaifeng Pharmaceutical Factory in Henan Province, a national comprehensive large class II pharmaceutical enterprise.

The company covers an area of 400000 square meters, a construction area of 170000 square meters, and more than 3000 large and medium-sized advanced production equipment. The production equipment of the enterprise is advanced and perfect, and has fully passed GMP certification and relevant acceptance. Kaiyao group is a high-tech enterprise in Henan Province, with perfect quality assurance system and quality detection and control instruments, and reliable product quality. All kinds of products produced have been spot checked by national, provincial and municipal quality supervision departments, and the qualified rate has been 100% for 23 consecutive years. The product quality meets the standards of Chinese Pharmacopoeia, British Pharmacopoeia, European Pharmacopoeia and American Pharmacopoeia. It is the first self-supporting import and export enterprise in the pharmaceutical system of Henan Province approved by the Ministry of foreign economic relations and trade.

Staff size:900-999 persons

Registered capital:RMB 204 million 568 thousand and 562

Producer:Jiangsu Nhwa Pharmaceutical Co., Ltd.  founded in 1978 and listed on Shenzhen Stock Exchange in 2008, is a pharmaceutical enterprise integrating science, industry and trade.

It has three large pharmaceutical GMP production bases for APIs and preparations, covering a total area of more than 900 mu. The enterprise has national certified workshops for APIs, solid preparations, water injections and lyophilized powder injections, and more than 10 automatic production lines for tablets, capsules, water injections and powder injections. At present, there are 39 kinds of APIs, 300 tons / year; More than 100 kinds of Western medicine preparations, 4 billion tablets (tablets) of solid preparations per year and 100 million injections per year.

According to the enterprise development strategy, we have made great efforts to save energy, reduce consumption and protect the environment, passed the international environmental certification (ISO14000), vigorously developed the export business of API, carried out EU edmf and FDA certification, and strive to gain a place in the international market.

Staff size:About 5000 persons

Registered capital:RMB 1 billion 8 million